U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Bayer

Market Cap: US$20.5b

Operates as a life science company worldwide.

Avantor

Market Cap: US$10.4b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Viatris

Market Cap: US$9.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Merck

Market Cap: US$199.2b

Operates as a healthcare company worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$1.4b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Exact Sciences

Market Cap: US$8.3b

Provides cancer screening and diagnostic test products in the United States and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.7b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Agilent Technologies

Market Cap: US$29.3b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Incyte

Market Cap: US$11.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Jazz Pharmaceuticals

Market Cap: US$6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Elanco Animal Health

Market Cap: US$4.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Teva Pharmaceutical Industries

Market Cap: US$15.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BeiGene

Market Cap: US$24.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

IQVIA Holdings

Market Cap: US$25.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Collegium Pharmaceutical

Market Cap: US$828.1m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Evolus

Market Cap: US$606.6m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Indivior

Market Cap: US$879.6m

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Day One Biopharmaceuticals

Market Cap: US$721.6m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Fennec Pharmaceuticals

Market Cap: US$138.2m

Operates as a commercial stage biopharmaceutical company in the United States.

Mirum Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Protagonist Therapeutics

Market Cap: US$2.6b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Amneal Pharmaceuticals

Market Cap: US$2.2b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Alkermes

Market Cap: US$4.4b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Gerresheimer

Market Cap: US$1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

UroGen Pharma

Market Cap: US$466.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Protara Therapeutics

Market Cap: US$143.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Vanda Pharmaceuticals

Market Cap: US$240.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Vetoquinol

Market Cap: US$892.2m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

OptiNose

Market Cap: US$91.4m

A specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists.

ACADIA Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Biogen

Market Cap: US$16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Halozyme Therapeutics

Market Cap: US$7.4b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Exelixis

Market Cap: US$9.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Curaleaf Holdings

Market Cap: US$847.1m

Produces and distributes cannabis products in the United States and internationally.

Cresco Labs

Market Cap: US$382.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.